Cassandra Pike, DPM
Podiatrist · Spartanburg, SCNPI 1538113279
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Zyla Life Sciences, Inc. at 39.5% of the total. Reporting peaked in 2019 at $513 and has fallen 80.6% since, to $99 in 2025. That places this record below the midpoint for podiatrist clinicians in SC, where the typical reported total is $1,261.
Across 110 payments — averaging $9.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zyla Life Sciences, Inc.$415
- Smith+Nephew$111
- Sebela Pharmaceuticals Inc.$97
- Organogenesis Inc.$91
- Stryker$50
- Kerecis Limited$35
- plus $252 from 12 others
What the payments were for
- Food & beverage$1,03999%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zyla Life Sciences, Inc. | 72 | $415 |
| Smith+Nephew | 5 | $111 |
| Sebela Pharmaceuticals Inc. | 6 | $97 |
| Organogenesis Inc. | 5 | $91 |
| Stryker(2 entities) | 3 | $50 |
| Kerecis Limited | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Abbott | 2 | $33 |
| Melinta Therapeutics, LLC | 2 | $28 |
| Amgen | 2 | $27 |
| Arthrosurface Incorporated | 2 | $27 |
| Globus Medical | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $18 |
| Biotissue Holdings Inc. | 1 | $16 |
| Linvatec Corporation | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
| Hikma Pharmaceuticals USA | 1 | $11 |
How this compares
$1,051 in reported general payments places this provider in the 45th percentile of 61 podiatrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 20 | $16,356 |
| Ciclopirox | 41 | $2,269 |
| Pregabalin | 12 | $791 |
| Mupirocin | 63 | $473 |
| CiclopiroxCiclopirox Olamine | 34 | $351 |
| Gabapentin | 20 | $182 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Spartanburg
- Henry McAninchSpartanburg$20
- Brandon PercivalLancaster$136K
- Alan BlockFlorence$96K
- William LongSimpsonville$91K
- Michael McCannFlorence$15K
- Daniel MethuselahIrmo$14K
- Breelyn MilesLadson$13K
- Jeffrey YungHilton Head Island$11K
- Arthur StoneGreenville$11K
- Jamelah LemonMauldin$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.